[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Goodrx Holdings Inc Cl A (GDRX)

Goodrx Holdings Inc Cl A (GDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 791,346
  • Shares Outstanding, K 342,574
  • Annual Sales, $ 796,850 K
  • Annual Income, $ 30,440 K
  • EBIT $ 173 M
  • EBITDA $ 260 M
  • 60-Month Beta 1.47
  • Price/Sales 1.02
  • Price/Cash Flow 5.92
  • Price/Book 1.31

Options Overview Details

View History
  • Implied Volatility 79.77% (-8.68%)
  • Historical Volatility 45.46%
  • IV Percentile 18%
  • IV Rank 16.38%
  • IV High 174.19% on 12/29/25
  • IV Low 61.28% on 06/23/25
  • Expected Move (DTE 23) 0.34 (14.35%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 263
  • Volume Avg (30-Day) 1,324
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 25,871
  • Open Int (30-Day) 52,784
  • Expected Range 2.03 to 2.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.03
  • Number of Estimates 4
  • High Estimate $0.05
  • Low Estimate $0.01
  • Prior Year $0.05
  • Growth Rate Est. (year over year) -40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.90 +24.74%
on 03/31/26
2.42 -2.07%
on 04/21/26
+0.34 (+16.75%)
since 03/20/26
3-Month
1.77 +33.90%
on 03/02/26
2.68 -11.73%
on 02/05/26
-0.20 (-7.78%)
since 01/22/26
52-Week
1.77 +33.90%
on 03/02/26
5.81 -59.21%
on 10/09/25
-2.08 (-46.74%)
since 04/22/25

Most Recent Stories

More News
Healthcare Technology Stocks Q4 Recap: Benchmarking GoodRx (NASDAQ:GDRX)

Healthcare Technology Stocks Q4 Recap: Benchmarking GoodRx (NASDAQ:GDRX)

GDRX : 2.37 (+2.60%)
1 Cash-Producing Stock with Exciting Potential and 2 We Ignore

1 Cash-Producing Stock with Exciting Potential and 2 We Ignore

GDRX : 2.37 (+2.60%)
LYV : 154.63 (+0.82%)
OLLI : 89.34 (+1.36%)
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call

GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its first quarter 2026 financial...

GDRX : 2.37 (+2.60%)
3 Reasons GDRX is Risky and 1 Stock to Buy Instead

3 Reasons GDRX is Risky and 1 Stock to Buy Instead

GDRX : 2.37 (+2.60%)
Why GoodRx (GDRX) Stock Is Up Today

Why GoodRx (GDRX) Stock Is Up Today

GDRX : 2.37 (+2.60%)
GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price

Expands access to FDA-approved GLP-1 treatment with transparent pricing and integrated support through GoodRx for Weight Loss Brief Summary: ...

GDRX : 2.37 (+2.60%)
GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide

Eligible self-pay consumers can access Foundayo starting at $149 per month through GoodRx Brief Summary: GoodRx is expanding access...

GDRX : 2.37 (+2.60%)
1 Healthcare Stock on Our Watchlist and 2 We Avoid

1 Healthcare Stock on Our Watchlist and 2 We Avoid

USPH : 75.52 (-0.01%)
GDRX : 2.37 (+2.60%)
ABBV : 200.50 (-2.25%)
1 Value Stock with Exciting Potential and 2 Facing Challenges

1 Value Stock with Exciting Potential and 2 Facing Challenges

EVR : 352.01 (-0.40%)
GDRX : 2.37 (+2.60%)
SJM : 94.99 (-0.78%)
2 Small-Cap Stocks with Competitive Advantages and 1 That Underwhelm

2 Small-Cap Stocks with Competitive Advantages and 1 That Underwhelm

SFBS : 78.49 (-0.70%)
GDRX : 2.37 (+2.60%)
MEG : 20.79 (+1.07%)

Business Summary

GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California.

See More

Key Turning Points

3rd Resistance Point 2.48
2nd Resistance Point 2.44
1st Resistance Point 2.41
Last Price 2.37
1st Support Level 2.33
2nd Support Level 2.29
3rd Support Level 2.26

See More

52-Week High 5.81
Fibonacci 61.8% 4.27
Fibonacci 50% 3.79
Fibonacci 38.2% 3.31
Last Price 2.37
52-Week Low 1.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.